Announcements
Sidley Represents Valius Sciences in Financing Raising More Than US$10 Million for Future Cancer Diagnostics
April 23, 2026
Sidley represented Valius Sciences, a San Francisco-based healthcare diagnostics company focused on cancer treatment, in a Series Seed financing round that raised more than US$10 million. The round was led by 8VC and Basis Set Ventures.
More information about the transaction can be found here.
The Sidley team was led by Michael Podolny (Emerging Companies and Venture Capital) and included Daniel Wei (Emerging Companies and Venture Capital) and Laura DeMassa (M&A).
連絡先
得意分野
Suggested News & Insights
Sidley Represents Jiangsu Nhwa Pharmaceutical in Its US$517.5 Million Licensing Transaction With SomniveraSeptember 30, 2026Sidley Represents Bluevine in Its US$340 Million Acquisition by Valley National BankSeptember 28, 2026Sidley Represents Star51 Capital in Its Investment in UltraSight’s US$24 Million FinancingSeptember 25, 2026Sidley Represents Cymphony in Its US$30 Million Series A FinancingSeptember 18, 2026When the Meeting Minutes and the AI Transcript Don’t Match: Litigation Insights From Delaware ChancerySeptember 17, 2026Sidley Represents Noetive in US$41 Million Series Seed FinancingSeptember 17, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory